OCRL and oculocerebrorenal syndrome: Both PHETA1 and PHETA2 have a C-terminal phenylalanine-histidine motif (F&H motif) that serves as a binding site for OCRL, encoded by a gene that is mutated in Lowe syndrome (MIM #309000) (Pirruccello et al., 2011).